Abstract

The septum is a ventral forebrain structure known to regulate innate behaviors. During embryonic development, septal neurons are produced in multiple proliferative areas from neural progenitors following transcriptional programs that are still largely unknown. Here, we use a combination of single cell RNA sequencing, histology and genetic models to address how septal neuron diversity is established during neurogenesis. We find that the transcriptional profiles of septal progenitors change along neurogenesis, coinciding with the generation of distinct neuron types. We characterize the septal eminence, an anatomically distinct and transient proliferative zone composed of progenitors with distinctive molecular profiles, proliferative capacity and fate potential compared to the rostral septal progenitor zone. We show that Nkx2.1-expressing septal eminence progenitors give rise to neurons belonging to at least three morphological classes, born in temporal cohorts that are distributed across different septal nuclei in a sequential fountain-like pattern. Our study provides insight into the molecular programs that control the sequential production of different neuronal types in the septum, a structure with important roles in regulating mood and motivation.

Data availability

Sequencing data have been deposited in GEO under accession code GSE184879

The following data sets were generated

Article and author information

Author details

  1. Miguel Turrero García

    Harvard Medical School, Boston, United States
    For correspondence
    Miguel_TurreroGarcia@hms.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7294-169X
  2. Sarah K Stegmann

    Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Tiara E Lacey

    Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Christopher M Reid

    Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Sinisa Hrvatin

    Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Caleb Weinreb

    Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Manal A Adam

    Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. M Aurel Nagy

    Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Corey C Harwell

    Harvard Medical School, Boston, United States
    For correspondence
    Corey_Harwell@hms.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8043-5869

Funding

National Institute of Mental Health (R01MH119156)

  • Corey C Harwell

National Institute of Neurological Disorders and Stroke (R01NS102228)

  • Corey C Harwell

Ellen and Melvin Gordon Center for the Cure of Paralysis (Fellowship)

  • Miguel Turrero García

Boehringer Ingelheim Fonds (MD Fellowship)

  • Sarah K Stegmann

Bill and Melinda Gates Foundation (Millennium Scholarship)

  • Tiara E Lacey

Howard Hughes Medical Institute (Gilliam Fellowship for Advanced Study)

  • Christopher M Reid

Harvard Brain Science Initiative (Seed Grant)

  • Corey C Harwell

Giovanni Armenise-Harvard Foundation (Junior Faculty Award)

  • Corey C Harwell

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures conducted in this study followed experimental protocols approved by the Institutional Animal Care and Use Committee of Harvard Medical School (IS961-3 and IS677-3).

Copyright

© 2021, Turrero García et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,505
    views
  • 310
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Miguel Turrero García
  2. Sarah K Stegmann
  3. Tiara E Lacey
  4. Christopher M Reid
  5. Sinisa Hrvatin
  6. Caleb Weinreb
  7. Manal A Adam
  8. M Aurel Nagy
  9. Corey C Harwell
(2021)
Transcriptional profiling of sequentially generated septal neuron fates
eLife 10:e71545.
https://doi.org/10.7554/eLife.71545

Share this article

https://doi.org/10.7554/eLife.71545

Further reading

    1. Developmental Biology
    Nathaniel C Nelson, Matthias C Kugler
    Insight

    Cells called alveolar myofibroblasts, which have a central role in the development of the lung after birth, receive an orchestrated input from a range of different signaling pathways.

    1. Developmental Biology
    Imran S Khan, Christopher Molina ... Dean Sheppard
    Research Article

    Premature infants with bronchopulmonary dysplasia (BPD) have impaired alveolar gas exchange due to alveolar simplification and dysmorphic pulmonary vasculature. Advances in clinical care have improved survival for infants with BPD, but the overall incidence of BPD remains unchanged because we lack specific therapies to prevent this disease. Recent work has suggested a role for increased transforming growth factor-beta (TGFβ) signaling and myofibroblast populations in BPD pathogenesis, but the functional significance of each remains unclear. Here, we utilize multiple murine models of alveolar simplification and comparative single-cell RNA sequencing to identify shared mechanisms that could contribute to BPD pathogenesis. Single-cell RNA sequencing reveals a profound loss of myofibroblasts in two models of BPD and identifies gene expression signatures of increased TGFβ signaling, cell cycle arrest, and impaired proliferation in myofibroblasts. Using pharmacologic and genetic approaches, we find no evidence that increased TGFβ signaling in the lung mesenchyme contributes to alveolar simplification. In contrast, this is likely a failed compensatory response, since none of our approaches to inhibit TGFβ signaling protect mice from alveolar simplification due to hyperoxia while several make simplification worse. In contrast, we find that impaired myofibroblast proliferation is a central feature in several murine models of BPD, and we show that inhibiting myofibroblast proliferation is sufficient to cause pathologic alveolar simplification. Our results underscore the importance of impaired myofibroblast proliferation as a central feature of alveolar simplification and suggest that efforts to reverse this process could have therapeutic value in BPD.